Janus Henderson Investors US’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$897M Sell
36,071,996
-5,503,015
-13% -$134M 0.73% 18
2016
Q4
$900M Buy
41,575,011
+6,289,196
+18% +$137M 0.76% 17
2016
Q3
$840M Buy
35,285,815
+4,209,000
+14% +$100M 0.71% 22
2016
Q2
$726M Sell
31,076,815
-10,215,574
-25% -$221M 0.62% 28
2016
Q1
$777M Sell
41,292,389
-191,304
-0.5% -$3.36M 0.67% 25
2015
Q4
$765M Sell
41,483,693
-884,011
-2% -$15.8M 0.65% 27
2015
Q3
$695M Buy
42,367,704
+14,035,306
+50% +$240M 0.62% 28
2015
Q2
$501M Buy
28,332,398
+1,851,993
+7% +$33.1M 0.41% 50
2015
Q1
$470M Sell
26,480,405
-1,684,535
-6% -$26.6M 0.39% 57
2014
Q4
$373M Buy
28,164,940
+14,870,583
+112% +$190M 0.32% 77
2014
Q3
$157M Sell
13,294,357
-2,233,365
-14% -$28.1M 0.14% 199
2014
Q2
$198M Sell
15,527,722
-922,400
-6% -$12M 0.18% 157
2014
Q1
$222M Buy
16,450,122
+895,000
+6% +$11.7M 0.21% 127
2013
Q4
$187M Buy
15,555,122
+4,750,557
+44% +$56.1M 0.18% 157
2013
Q3
$127M Buy
10,804,565
+5,573,465
+107% +$60.3M 0.13% 215
2013
Q2
$48.5M Buy
+5,231,100
New +$44.4M 0.05% 367

Other funds holding BSX

Janus Henderson Investors US's BSX Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Boston Scientific (BSX) stake by 13% in Q1 2017, selling an estimated $134M and leaving 36,071,996 shares worth $897M. The position accounts for 0.73% of the portfolio, ranked #18.

Janus Henderson Investors US first reported a position in BSX in Q2 2013 and has held it in 16 quarters since. The position peaked at $900M in Q4 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

  • Janus Henderson Investors US held 36,071,996 shares of Boston Scientific worth $897M as of Q1 2017.
  • Janus Henderson Investors US sold 5,503,015 Boston Scientific shares in Q1 2017, an estimated $134M.
  • Boston Scientific made up 0.73% of Janus Henderson Investors US's portfolio in Q1 2017, its #18 holding.
  • Janus Henderson Investors US first reported a position in Boston Scientific in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Boston Scientific position peaked at $900M in Q4 2016.
  • 552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.